Total Payments
$7,743
2024 Payments
$888.98
Companies
28
Transactions
301
Medicare Patients
21,082
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$6,121 (79.0%)
Consulting$1,430 (18.5%)
Education$192.21 (2.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,121 | 296 | 79.0% |
| Consulting Fee | $1,430 | 1 | 18.5% |
| Education | $192.21 | 4 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $2,084 | 25 | $0 (2024) |
| ABBVIE INC. | $1,572 | 71 | $0 (2024) |
| Janssen Biotech, Inc. | $693.98 | 35 | $0 (2024) |
| Lilly USA, LLC | $569.77 | 20 | $0 (2024) |
| LEO Pharma Inc. | $372.25 | 22 | $0 (2024) |
| PFIZER INC. | $333.19 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $280.24 | 15 | $0 (2023) |
| UCB, Inc. | $269.86 | 6 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $225.70 | 14 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $201.77 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $888.98 | 41 | ABBVIE INC. ($330.31) |
| 2023 | $875.97 | 45 | AbbVie Inc. ($149.82) |
| 2022 | $951.46 | 49 | ABBVIE INC. ($268.50) |
| 2021 | $1,101 | 64 | AbbVie Inc. ($391.79) |
| 2020 | $613.03 | 33 | AbbVie Inc. ($124.94) |
| 2019 | $2,967 | 65 | GENZYME CORPORATION ($1,488) |
| 2018 | $223.77 | 3 | Lilly USA, LLC ($123.78) |
| 2017 | $121.85 | 1 | GENZYME CORPORATION ($121.85) |
All Payment Transactions
301 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $35.26 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Dentsply Sirona Inc | CAVITRON (Device) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Preventive Dentistry | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Immunology | ||||||
| 08/08/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: DERMATOLOGY | ||||||
| 08/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Dermatology | ||||||
| 07/31/2024 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: DERMATOLOGY | ||||||
| 07/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.15 | General |
| Category: Immunology | ||||||
| 06/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: IMMUNOLOGY | ||||||
| 06/22/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $33.78 | General |
| Category: ONCOLOGY | ||||||
| 06/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: IMMUNOLOGY | ||||||
| 05/06/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Podiatry | ||||||
| 04/21/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $1.19 | General |
| 04/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $1.20 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 5,000 | 11,469 | $1.0M | $386,001 |
| 2022 | 24 | 5,434 | 11,182 | $643,555 | $394,861 |
| 2021 | 25 | 6,176 | 12,565 | $1.1M | $490,321 |
| 2020 | 22 | 4,472 | 7,990 | $833,230 | $289,324 |
Total Patients
21,082
Total Services
43,206
Medicare Billing
$1.6M
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 950 | 1,355 | $198,281 | $77,429 | 39.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 740 | 1,043 | $174,177 | $69,069 | 39.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 387 | 1,059 | $89,014 | $40,979 | 46.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 844 | 1,243 | $134,294 | $40,469 | 30.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 682 | 5,108 | $54,345 | $25,357 | 46.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 220 | 262 | $55,647 | $21,674 | 38.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 128 | 181 | $56,524 | $21,081 | 37.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 131 | 163 | $45,529 | $19,288 | 42.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 207 | 229 | $41,523 | $16,555 | 39.9% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 118 | 164 | $43,566 | $14,155 | 32.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 178 | 178 | $27,982 | $10,123 | 36.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 31 | 32 | $18,895 | $7,521 | 39.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 148 | 159 | $13,801 | $5,681 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $10,951 | $4,535 | 41.4% |
| 69100 | Biopsy of ear | Office | 2023 | 66 | 71 | $11,797 | $3,386 | 28.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 24 | 25 | $11,826 | $2,392 | 20.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 21 | 24 | $4,211 | $1,935 | 46.0% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $3,908 | $1,476 | 37.8% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 13 | 13 | $3,948 | $1,368 | 34.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 31 | 31 | $3,048 | $1,244 | 40.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 24 | $569.08 | $242.00 | 42.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 50 | $91.89 | $42.10 | 45.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 995 | 1,455 | $131,716 | $81,983 | 62.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 767 | 989 | $101,371 | $64,823 | 63.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 865 | 1,186 | $79,626 | $38,835 | 48.8% |
About Dr. Michael Christopher, M.D
Dr. Michael Christopher, M.D is a Dermatology healthcare provider based in Madison, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2015. The National Provider Identifier (NPI) number assigned to this provider is 1477932796.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Christopher, M.D has received a total of $7,743 in payments from pharmaceutical and medical device companies, with $888.98 received in 2024. These payments were reported across 301 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($6,121).
As a Medicare-enrolled provider, Christopher has provided services to 21,082 Medicare beneficiaries, totaling 43,206 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Madison, WI
- Active Since 05/19/2015
- Last Updated 03/17/2017
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1477932796
Products in Payments
- DUPIXENT (Drug) $1,570
- SKYRIZI (Biological) $761.38
- DUPIXENT (Biological) $640.71
- TALTZ (Drug) $569.77
- REMICADE (Biological) $374.38
- EUCRISA (Drug) $317.92
- HUMIRA (Biological) $314.91
- Humira (Biological) $257.93
- COSENTYX (Biological) $244.43
- Cimzia (Drug) $229.13
- ADBRY (Biological) $215.37
- Tremfya (Drug) $171.99
- TREMFYA (Drug) $147.61
- ENSTILAR (Drug) $142.98
- ATOPIC DERMATITIS - DISEASE (Drug) $121.85
- AKLIEF (Drug) $121.53
- Otezla (Drug) $93.18
- JUBLIA (Drug) $90.79
- ABSORICA (Drug) $84.26
- ILUMYA (Biological) $81.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Madison
Dr. Jeremy Moss, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $2.5M
Dermatology $2.5M
Molly Hinshaw, Md, MD
Dermatology — Payments: $241,363
Dermatology $241,363
Dr. Stefan Schieke, M.d, M.D
Dermatology — Payments: $6,859
Dermatology $6,859
Dr. Harry Sharata, Md, Ph.d, MD, PH.D
Dermatology — Payments: $5,309
Dermatology $5,309
Dr. Joseph Dai, M.d, M.D
Dermatology — Payments: $4,865
Dermatology $4,865
Brittany Buhalog, M.d, M.D
Dermatology — Payments: $4,270
Dermatology $4,270